Michael Sabel
Düsseldorf University Hospital(DE)Integrated Oncology (United States)(US)Heinrich Heine University Düsseldorf(DE)RWTH Aachen University(DE)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Meningioma and schwannoma management, Medical Imaging Techniques and Applications, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial(2012)1,112 cited
- → Long-term survival with glioblastoma multiforme(2007)890 cited
- → NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide(2009)804 cited
- → Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial(2019)568 cited
- → Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups(2015)314 cited
- → MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial